Sell. Extreme valuation divergence completely overrides exceptional business quality.
Bull: Execution remains flawless and the market tolerates an extended high multiple. However, the stock remains structurally overvalued relative to intrinsic cash flows.
Multiple Normalization: Forward P/E compresses from >45x to the historical 25x cap, causing massive equity destruction despite stable operations.
Sell. Costco is a premier business priced at an irrational valuation. Re-evaluate only after a severe multiple normalization event.
Position sizing playbook →| Market cap | $448.8B | |
|---|---|---|
| Revenue (ttm) | 286.3B | |
| Net income (ttm) | 8.5B | |
| EPS (ttm) | $19.2 | |
| Shares out | 443.7M | |
| P/E (trailing) | 52.5x | |
| P/E (forward) | 45.0x | |
| Dividend | $5.88 (0.58%) | |
| Volume | 1,804,960 | |
| Beta | 0.91 | |
| Price target | $1078 | +6.9% |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | Trend |
| Revenue | $226.95B | $242.29B | $254.45B | $275.24B | +6.6% |
| Gross profit | $27.57B | $29.70B | $32.10B | $35.35B | +8.6% |
| Operating income | $7.79B | $8.11B | $9.29B | $10.38B | +10.0% |
| Net income | $5.84B | $6.29B | $7.37B | $8.10B | +11.5% |
| EPS (diluted) | $13.14 | $14.16 | $16.56 | $18.21 | +11.5% |
| EBITDA | $9.90B | $10.72B | $12.15B | $13.40B | +10.6% |
| R&D | — | — | — | — | — |
| SG&A | $19.78B | $21.59B | $22.81B | $24.97B | +8.1% |
| Model | Fair value (mid) | Weight |
|---|---|---|
| Multi stage moat fade | $532 | 35% |
| Owner earnings | $616 | 25% |
| Forward earnings | $523 | 20% |
| Discounted earnings | $455 | 10% |
| FCFF DCF | $435 | 10% |
| Reverse DCF | $0.00 | 0% |
| Peg adjusted peer | $333 | 0% |
Recent company headlines from major financial publishers.
Execution remains flawless and the market tolerates an extended high multiple. However, the stock remains structurally overvalued relative to intrinsic cash flows.
Revenue growth normalizes to 3-5% long-term, and the multiple reverts to an appropriate 25x mature compounder ceiling, exposing the massive valuation gap.
Severe multiple compression materializes alongside sluggish consumer discretionary spending, pushing the valuation toward its $385 downside bound.
| Model | Weight | FV / share | vs spot | Contribution |
|---|---|---|---|---|
| Multi stage moat fade | 35% | $532 | -47.3% | |
| Owner earnings | 25% | $616 | -39.0% | |
| Forward earnings | 20% | $523 | -48.2% | |
| Discounted earnings | 10% | $455 | -54.9% | |
| FCFF DCF | 10% | $435 | -56.9% | |
| Reverse DCF | 0% | $0.00 | -100.0% | |
| Peg adjusted peer | 0% | $333 | -67.0% | |
| Composite FV (weighted) | 100% | $534 | -47.3% |
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.0% | $663 | $757 | $881 | $930 | $930 |
| 7.0% | $532 | $590 | $663 | $757 | $881 |
| 8.0% | $444 | $484 | $532 | $590 | $663 |
| 9.0% | $381 | $410 | $444 | $484 | $532 |
| 10.0% | $333 | $355 | $381 | $410 | $444 |
| Category | Weight | Score | Reading |
|---|---|---|---|
| Valuation | 11% | 5.0 | |
| Management | 11% | 6.9 | |
| Balance Sheet | 11% | 6.0 | |
| Profitability | 11% | 7.0 | |
| Revenue Growth | 11% | 7.5 | |
| Risk Assessment | 11% | 6.5 | |
| Competitive Moat | 11% | 9.0 | |
| Earnings Quality | 11% | 9.0 | |
| Capital Efficiency | 11% | 6.0 |
Upcoming earnings date and setup when available.